Mandashi participates in £1M raise for local biotech startup Phast

Mandashi is pleased to announce its participation in Sheffield based Phast's pre-seed funding round, led by Sheffield Angels, with participation from Cambridge Angels, contributing a combined £500,000 in equity investment. This investment has been matched through a £500,000 Innovate UK Investor Partnership Grant, bringing the total funding secured to £1 million.

This milestone represents an important step in Phast's mission to accelerate the adoption of sustainable, high-performance biopolymers for medical applications. The funding will enable Phast to expand its R&D activities, strengthen its team, advance product development, and accelerate the commercialisation of its next-generation PHA-based medical products.